Rosetta Genomics (Rosetta Genomics) Debt-to-Equity : 2.23 (As of Jun. 2017)

Rosetta Genomics Debt-to-Equity Chart

Rosetta Genomics Annual Data
	Trend	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16
Debt-to-Equity		Get a 7-Day Free Trial					-	-	-	-	0.86

Rosetta Genomics Quarterly Data
	Dec10	Mar11	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17
Debt-to-Equity	Get a 7-Day Free Trial															-	0.01	0.02	0.86	2.23

Competitive Comparison of Rosetta Genomics's Debt-to-Equity

For the Diagnostics & Research subindustry, Rosetta Genomics's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rosetta Genomics's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Rosetta Genomics's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Rosetta Genomics's Debt-to-Equity falls into.

Rosetta Genomics Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Rosetta Genomics's Debt to Equity Ratio for the fiscal year that ended in Dec. 2016 is calculated as

Rosetta Genomics's Debt to Equity Ratio for the quarter that ended in Jun. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics  (OTCPK:ROSGQ) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Rosetta Genomics Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Rosetta Genomics's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Rosetta Genomics (Rosetta Genomics) Business Description